FarmaMondo is delighted to participate again in BIO in Boston. Nicolas Moretti, Managing Director Corporate Development, and Marco Scicolone, Head of BD and Alliances, attend this convention again. A hectic marathon of 4 intense days with current and future partners.
We discover new assets in oncology, orphan disease and continue to focus on high unmet medical need for in paediatric and adult patients. We also present to our partners our high value end-to-end commercialization partnership across emerging markets and our massive progresses in the last years and our next developments.
Leveraging our unique expertise and geographic footprint, we help bring innovative and specialty medicines to patients in need.
We look forward to following up these contacts in the next weeks!
